Research programme: cardiovascular disorder therapeutics - 4SC Discovery/University of Munich
Latest Information Update: 28 Jul 2018
At a glance
- Originator 4SC Discovery
- Developer 4SC Discovery; University of Munich
- Class Small molecules
- Mechanism of Action ADAM protein modulators; Histone deacetylase modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cardiovascular disorders
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for research development in Cardiovascular-disorders in Germany
- 15 Apr 2014 Early research in Cardiovascular disorders in Germany (unspecified route)